Is ______ Peptide Legal?

Three Categories Exist:

1. Approved for Compounding

These are active ingredients in FDA-approved drugs or have a recognized monograph, making them legal for pharmacies to compound.

First 5 are for weight loss or body composition:

Liraglutide
Semaglutide
Sermorelin
Tesamorelin
Tirzepatide

——-

GHK-Cu (Approved for topical use, skin benefits)
NAD+ – mitochondria / energy / inflammation (small molecule, technically not a peptide)

In October 2026:

The Department of Health and Human Services (HHS), led by Secretary Robert F. Kennedy Jr., issued an interim enforcement discretion policy that allows state-licensed 503A compounding pharmacies, federal facilities, and licensed physicians to manufacture and prescribe six unapproved wellness peptides.

To learn more you can click on their names in the below section

2. Legal to Purchase / Not allowed for Compounding

This category is legal to purchase for research purposes but have not been approved for compounding in a pharmacy.

What it typically means is they don’t have enough information or that no application has been made.

Due to the update in October 2026 being temporary, the 6 peptides removed from Category 2 are simply crossed out below.

•••

Because the brands we use are all 3rd Party tested and held to impeccable standards, they remain the most straightforward and cost effective method to obtain these:

5-Amino-1MQ – Fat cell metabolism / energy / mitochondria (this is a small molecule, not a peptide)
AOD-9604
ARA-290 – Nerve pain & regeneration
~~BPC-157~~ – healing but mast cell issues are reported, we prefer TB4
CJC-1295
Dihexa
DSIP – Delta Sleep Inducing Peptide
~~Epitalon~~ – anti-aging / circadian rhythm
GHK-Cu (injectable form)
Ipamorelin
~~KPV~~ – anti inflammatory, antifungal, antibacterial, mast cell calming
Larazotide
~~LL37~~
Melanotan I & II
~~MOTS-c~~ (many issues reported, we prefer small molecule NAD+ for mitochondria)
P-21
PEG-MGF
Selank – anti anxiety
~~Semax~~
Thymogen Alpha 1 – immune system regulation
Thymosin Alpha-1
~~TB-500~~ ~~(Frag 17-23)~~ and TB4 Frag 1-4 (Thymosin Beta 4 Fragments) – tissue healing
Organ Bioregulators (Adrenals, Bladder, Blood Vessels, Bone Marrow, Brain, Cartilage, Eyes, Heart, Kidneys, Liver, Lungs, Muscle, Ovaries, Pancreas, Parathyroid, Pineal Gland, Prostate, Retina, Stomach, Testes, Thymus, Thyroid)
Other Peptides not listed but mentioned on this page

3. FDA Banned / Illegal to Purchase

These are specific investigational or counterfeit substances that the FDA has targeted with Import Alerts or Warning Letters, making their sale illegal even when labeled for research.

Retatrutide
Cagrilintide
Counterfeit GLP-1s (Any generic version of a patented drug sourced from unverified foreign suppliers)

October 2026 Update:

As mentioned, the HHS updated the 503A Categories list – removing 6 peptides from Category 2

• Criteria that must be met: By prescription only, no mass production, only one per container (no combo forumlas)

• Enforcement discretion: While these substances remain technically unapproved by the FDA, the federal government is choosing to “look the other way” and pause legal action against qualified pharmacies that produce them, provided strict safeguards are met.

This serves as a temporary bridge while the FDA works through the formal, lengthier rulemaking process to officially add them to the 503A Bulk Drug Substances List.

• Does this mean we can more openly discuss them on Social Media?

We’ll have to wait and see – it will require the platforms updating their algorithms which would take a very long time and unlikely due to Pharma influence over the platforms.

Older news – March 2026

(This didn’t happen)

As of March 3, 2026, Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. reported that 14 of the 19 peptides currently on the FDA Category 2 list (prohibited for compounding) will be moved to Category 1 (allowable) in the coming weeks.

While the official FDA list is still pending finalization, industry experts and reports from the Alliance for Pharmacy Compounding identify the following as the primary candidates for re-approval: